After COVID-19, we must rethink how we find and produce new drugs

drugs__

(Credit: Unsplash)

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: André Loesekrug-Pietri, Chairman, Joint European Disruptive Initiative & Thomas Hermans, Programme Manager, JEDI Covid19 GrandChallenge, and Professor, University of Strasbourg


  • How we produce and distribute any vaccine is an issue we need to address.
  • The nature of the vaccine manufacturing process promotes inequality in who benefits and when.
  • We must now be creative and experimental today to ensure we are prepared for the pandemics of the future.

As the race for a COVID-19 vaccine continues, the Billion Molecules Against COVID-19 Global GrandChallenge – organised by the Joint European Disruptive Initiative (JEDI) – kicked off on 4 May. At the same time, the European Union – in cooperation with France, Germany, the UK, Norway and Saudi Arabia – launched a massive fundraising marathon. Its purpose is twofold: firstly to accelerate the development and deployment of tests, treatments and vaccines, and secondly to ensure that as many players as possible undertake to make them accessible to all countries. And the EU is thinking big money, as always: it has raised no less than €7.5 billion ($8.3 billion) in initial funding.

Although the ambition of this EU fundraising is laudable, the issue of worldwide distribution of the vaccine still needs to be addressed. Pharma players capable of producing massive numbers of doses are rare. In recent weeks, partnerships have multiplied between large laboratories to increase their production capacities: Moderna and Lonza Group aim for a billion doses per year, while AstraZeneca and the University of Oxford hope to be able to supply 100 million doses before the end of the year. The American Inovio Pharmaceuticals and the German Richter-Helm Biologics have joined forces for the same purpose, as well as the arch-rivals Sanofi (French) and GlaxoSmithKline (English).

 

More than just the question of when a vaccine will be discovered – and the German Minister of Health poured cold water on hopes this could happen anytime soon – the question of which laboratory will discover it, the quantity of doses that can be produced and their accessibility are eminently strategic and a major challenge for humanity. The challenge of vaccination is twofold: in addition to protecting citizens, it also offers the hope of returning economies to normal without fear of a ‘second wave’.

However, if tests conducted by American laboratories prove conclusive, it is likely that the American population will be heavily prioritized. And what is already problematic for Europe is likely to prove disastrous for countries that have neither the infrastructure, the financial means, nor the manpower of Western countries. The vaccine-manufacturing process is slow and expensive, and as such it automatically promotes inequality.

Tackling this challenge requires collective action to ensure massive production and equitable distribution. Besides the question of financing, on which the Coalition for Epidemic Preparedness Innovations (CEPI) and the World Bank are actively working, transforming production processes to make them more efficient is also crucial. Process intensification is a possible approach; this would aim to minimize the equipment and space used, thus reducing both its costs and its risks and potentially enabling a vaccine to be produced anywhere in the world on a distributed basis.

Several players have already taken this process intensification route, such as the Belgian company Univercells and the Dutch firm Batavia. So have pharmaceutical companies such as Janssen and Merck, as well as the technology and service provider Cytiva. But obstacles remain numerous, and it is a scientific and industrial frontier that we must address with energy and determination.

If the European Union wishes to live up to the challenge it has launched, funding the design and production of vaccines and treatments will not be not enough. Let us use this historic and planetary crisis to imagine solutions that are both scientifically robust and radically new. We can develop and produce solutions through distributed production, 3D printing. We need to bring together disciplines and new capabilities brought by high-performance computing, machine learning and molecular biology to screen billions of molecules like the JEDI COVID-19 GrandChallenge. We need to fast-track drug discovery by having even better-qualified compounds enter clinical trials, compounds that could be cross-correlated by teams from across the globe. We need to tap into collective intelligence, be creative, experimental, and willing to push the limits of science and technology – because it is as much the sovereignty of each nation, as well the equality of access to care throughout the world, which are at stake.

Indeed, with the coronavirus monopolizing our attention, it would be absurd not to prepare today for the epidemics of tomorrow. The number of pathogens with pandemic potential are many, and some have much higher mortality rates than the coronavirus. To get out of the current tragedy and not return to the same state of affairs when the next major disease strikes, we must take heed of the French poet and philosopher Paul Valéry’s call to Europeans: “Well, what are you going to do? What are you going to do today?”

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

COVID-19 tracing apps: MEPs stress the need to preserve citizens’ privacy

Coronavirus: Commission launches data sharing platform for researchers

Mental health in times of a pandemic: what can each individual do to lessen the burden?

Can we put a price on clean air? Yes, we can

EU security and defence industry prepares positions for ‘producers’ and ‘customers’

Here’s how the EU is doing on gender equality

UN urges protection of indigenous peoples’ rights during migration

UN agencies welcome green light for Rohingya projects in northern Myanmar; urge ‘more effective access’

Combatting terrorism: EP special committee calls for closer EU cooperation

Italian elections: a long political limbo is ahead

The European Sting @ European Business Summit 2014 – the preview

The dangers of data: why the numbers never tell the full story

How climate change sparks innovation for fragile communities

Car rentals: EU action leads to clearer and more transparent pricing

How to build deforestation-free supply chains: lessons from Indonesia

Financing economic recovery, written by United Nations Under-Secretary-General

The Shifting Rhythms of Harmonious China: Ancient, Modern & Eternal

Alternative proteins will transform food, mitigate climate change and drive profits. Here’s how

Coronavirus: How worried should we be?

The online junk information grows, but so we shall

Somalia advancing towards ‘inclusive and peaceful future’ for women, deputy UN chief

We should look to nature for solutions to the global water crisis. Here’s why

Coronavirus: Commission boosts urgently needed research and innovation with additional €122 million

GSMA Mobile 360 – Africa on 16-18 July 2019, in association with The European Sting

Apple’s tax avoidance scheme remains as creative as their new iPhone

Polluted lungs: health in the center of environment discussion

A Sting Exclusive: “The Chinese economy is steady and moving in the right direction”, Ambassador Yang of the Chinese Mission to EU underscores from Brussels

Mobile technology saving lives: changing healthcare with simple technology solutions

Social Committee slams the 28 EU leaders for false promises

Turning challenge into opportunity on the course to becoming the first climate-neutral continent

Main results of European Council of 18/10/2018

How artificial intelligence is redefining the role of manager

Local innovation, international impact: SMEs and the ITU Telecom World Awards

What makes a great CEO? The people they surround themselves with

Historian Niall Ferguson on what the pandemic means for the global economy, geopolitics – and parties

EU allocates over €22 million to help Palestinians in need

Digital business is Europe’s best hope to get back to growth

Mental Health of Health Professionals Facing COVID-19

How blockchain can cut the cost of new medicine

Trump asked Merkel to pay NATO arrears and cut down exports ignoring the EU

How digital can transform healthcare in Asia for millions of people

The Venezuelan exodus to Roraima and its repercussions

Criminals thrive on data abundance – here’s how we’ll catch them

Brexit kick-off: a historic day for the EU anticlockwise

UN food relief agency airlifts aid to DR Congo province hit by Ebola outbreak

EU Migrant Crisis: Italian Coast Guard Headquarters and Italian Navy to give host national opening addresses at Border Security 2016 in Rome

Paris is building the world’s greenest business district. What can other cities learn from it?

EU trade agreements: delivering new opportunities in time of global economic uncertainties

Women outliving men ‘everywhere’, new UN health agency statistics report shows

What universities can learn about citizenship in the COVID-19 pandemic

Libya: UN Mission condemns deadly attack against police in country’s south-east

Human rights: Chad, Haiti and Armenian prisoners of war in Azerbaijan

How COVID-19 accelerated the shift towards TradeTech

The key takeaways of G7 Summit in Canada

AI strawberries and blockchain chicken: how digital agriculture could rescue global food security

This is the hidden connection between smuggling and climate change

The secret to Bangladesh’s economic success? The Sheikh Hasina factor

EU steps up its strategy for connecting Europe and Asia

‘Alarmingly high’ number of children malnourished worldwide: UNICEF report

Being blinded by labels stops social change. Art helps us see a better future

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s